Skip to main

News

DOJ Charges Two with Smuggling Counterfeit Ozempic

30 September 2026

Two Indian nationals face federal charges in Florida for allegedly conspiring to smuggle counterfeit Ozempic from China into the United States.

The Department of Justice unsealed an indictment charging Swapnadip Roy, 33, and Vicky Ramancha, 37, with one count of conspiracy to commit smuggling and defraud the U.S., three counts of smuggling, and two counts of selling or holding counterfeit drugs for sale.

Prosecutors allege the scheme ran from July 2023 to April 2024. The defendants purportedly obtained counterfeit pens, packaging, labels, and needles from unauthorized sources in China to deceive buyers.

Roy was extradited from Italy and appeared in U.S. District Court in Tampa. Ramancha remains at large. Court documents describe agreements to supply discounted counterfeit product to Florida companies and threats used to facilitate distribution.

The operation allegedly continued after FDA seizures and public warnings about fake Ozempic in 2023. Conviction on all counts could result in up to 71 years in prison.

The case highlights ongoing enforcement against counterfeit pharmaceuticals amid rising demand for GLP-1 medications.

Sources: https://www.cnbc.com/2026/09/29/ozempiz-counterfeit-china-smuggling-doj.html https://www.justice.gov/

Share